The ERK and JNK pathways in the regulation of metabolic reprogramming

Area of Science:

• Molecular Biology
• Cancer Metabolism
• Cell Signaling

Background:

• Tumor cells exhibit altered glucose metabolism (Warburg effect) due to oncogenic mutations, supporting proliferation and survival.
• The Warburg effect, or aerobic glycolysis, is a hallmark of cancer, enabling rapid cell growth and evasion of apoptosis.
• Signaling pathways regulating this metabolic shift are attractive anticancer targets, but their roles in normal physiology must be assessed.

Purpose of the Study:

• To review the role of Mitogen-Activated Protein Kinase (MAPK) pathways, specifically ERK and JNK, in regulating the Warburg effect in cancer.
• To discuss the involvement of ERK and JNK pathways in controlling the Warburg effect during normal physiological processes.
• To explore therapeutic opportunities targeting downstream effectors of ERK and JNK pathways for cancer treatment.

Main Methods:

• Literature review summarizing current research on MAPK pathways and cancer metabolism.
• Analysis of studies investigating the Warburg effect in both tumorigenesis and physiological contexts.
• Discussion of potential therapeutic strategies targeting ERK and JNK signaling.

Main Results:

• ERK and JNK pathways are identified as key regulators of the Warburg effect in cancer cells.
• These pathways also play significant roles in controlling metabolic reprogramming in normal cellular functions.
• Evidence suggests that targeting downstream effectors of these pathways could be a viable therapeutic approach.

Conclusions:

• The MAPK/ERK and MAPK/JNK pathways are critical regulators of the Warburg effect in cancer.
• Understanding their dual role in cancer and normal physiology is essential for developing effective therapies.
• Targeting downstream effectors presents a promising strategy for anticancer interventions with potentially fewer side effects.